Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Chemical & Pharmaceutical Bulletin|June 11, 1998
Antiproliferative constituents in umbelliferae plants. III. Constituents in the root and the ground part of Anthriscus sylvestris HoffmR Ikeda, T Nagao, H Okabe, et al.
Journal of Surgical Oncology|February 11, 1998
Expression of interleukin (IL)-12 mRNA in gastric carcinoma specimens: cellular antitumor immune responsesM Katano, M Nakamura, A Kuwahara, et al.
Biological & Pharmaceutical Bulletin|June 1, 1994
A highly sensitive enzyme-linked immunosorbent assay (ELISA) for antitumor polyacetylenic alcohol, panaxytriolT Saita, H Matsunaga, H Yamamoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[Strategy for therapy of malignant ascites using MTT assay]M Katano, K Oogushi, H Morita, et al.
Annals of Surgical Oncology|June 16, 2001
Association of enhanced cyclooxygenase-2 expression with possible local immunosuppression in human colorectal carcinomasM Kojima, T Morisaki, A Uchiyama, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell aloneM Katano, F Nagumo, E Kubota, et al.
Clinical Immunology and Immunopathology|March 1, 1996
Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-gamma in enhancement of surface expression of ICAM-1 on tumor cells in vivoH Kitsuki, M Katano, A Ikubo, et al.
Clinical Immunology and Immunopathology|October 1, 1995
A possible role of TGF-beta in the formation of malignant effusionsA Ikubo, T Morisaki, M Katano, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|September 11, 2004
Construction of a transplantable tissue-engineered artificial peritoneumH Kuga, T Morisaki, K Nakamura, et al.
Gut|November 22, 2005
Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activationT Akiyoshi, M Nakamura, K Koga, et al.
Pageof 9